Pictet Asset Management (Switzerland)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$287M Buy
610,930
+42,553
+7% +$17.8M 0.34% 83
2023
Q1
$195M Sell
568,377
-18,967
-3% -$6.4M 0.24% 123
2022
Q4
$188M Buy
587,344
+5,643
+1% +$2M 0.27% 112
2022
Q3
$188M Buy
581,701
+57
+0% +$18.1K 0.28% 106
2022
Q2
$189M Sell
581,644
-35,670
-6% -$10.7M 0.26% 117
2022
Q1
$177M Sell
617,314
-23,659
-4% -$6.09M 0.2% 150
2021
Q4
$177M Sell
640,973
-125,957
-16% -$31.9M 0.18% 164
2021
Q3
$177M Buy
+766,930
New +$189M 0.2% 152

Other funds holding LLY

Pictet Asset Management (Switzerland)'s LLY Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Eli Lilly (LLY) stake by 7.5% in Q2 2023, buying an estimated $17.8M and bringing the position to 610,930 shares worth $287M. The position accounts for 0.34% of the portfolio, ranked #83.

Pictet Asset Management (Switzerland) first reported a position in LLY in Q3 2021 and has held it in 8 quarters since. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 610,930 shares of Eli Lilly worth $287M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 42,553 Eli Lilly shares in Q2 2023, an estimated $17.8M.
  • Eli Lilly made up 0.34% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #83 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Eli Lilly in Q3 2021 and has held it in 8 quarters since.
  • 2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.